Innovative Field Applications of Probiotics, Prebiotics, and Medicinal Plant Products for Disease Control in Aquaculture

ABSTRACT

Disease outbreaks and the associated reliance on antibiotics pose major constraints to the sustainability of modern aquaculture. As regulatory pressures increase and consumer demand shifts toward residue‐free production, diverse biological interventions are gaining prominence as viable alternatives to chemotherapeutics. These include microbiome‐modulating agents (probiotics, classical prebiotics, and synbiotics), alongside a distinctly separate category of functional additives: phytogenics (medicinal plant derivatives), which are valued for their direct bioactive and immunomodulatory properties. This review synthesizes current laboratory and field‐based evidence regarding the efficacy, mechanisms, and practical challenges of these functional additives. While in vitro and controlled studies demonstrate clear benefits in immune modulation, competitive exclusion, and gut health, real‐world application is frequently hindered by environmental inconsistencies and formulation instability. We critically evaluate the impact of system‐specific variables and draw several specific mechanistic inferences: First, the over‐reliance on static in vitro assays fundamentally fails to predict in vivo colonization under multifactorial field stress (e.g., thermal and pH fluctuations). Second, thermal degradation during industrial feed extrusion is a primary driver of batch‐to‐batch inconsistency, rendering advanced microencapsulation and post‐coating techniques practically mandatory for viable delivery. Third, the efficacy of functional additives is strictly governed by the culture matrix; while the chemical stability of Recirculating Aquaculture Systems (RAS) yields predictable outcomes, open ponds face severe abiotic fluctuations, and Biofloc Technology (BFT) requires precise Carbon‐to‐Nitrogen (C:N) stoichiometry to facilitate heterotrophic assimilation. To overcome these limitations, we propose a strategic shift toward next‐generation interventions specifically thermal‐stable postbiotics, precision phage therapy for niche‐clearing, and rigorous multi‐omics technologies for molecular validation, replacing purely phenotypic observations. By integrating these specific innovations within a precision digital health framework, this work provides a comprehensive roadmap for standardizing bio‐based disease control for sustainable and reproducible aquaculture production.